Illumina has recently advanced its plan to divest its cancer-diagnostics unit, a move intended to ease regulatory pressure and sharpen its focus on core DNA sequencing and microarray technologies.

The Global Reproductive Genetics Market is estimated to be valued at USD 7.31 Bn in 2025 and is expected to reach USD 16.67 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 12.5% from ...

One of the most detailed 3D maps of how the human chromosomes are organized and folded within a cell's nucleus is published in Nature. Chromosomes are thread-like structures that carry a cell's ...

The song has been streamed over 3 million times in under a month. A song created through artificial intelligence has made history topping a Billboard country music chart, but it has also sent ...

Stock market graphs don’t have to be a mystery. Here’s how to read stock charts for any company. Many, or all, of the products featured on this page are from our advertising partners who compensate us ...

Stella Osoba is the Senior Editor of trading and investing at Investopedia. She co-founded and chaired Women in Technical Analysis. She has 15+ years of experience as a financial writer and technical ...

Reported Data Supports the Potential Extension of HD-MAP Vaccine Delivery to Oncology Indications Recently published data generated by researchers at The University of Queensland and Vaxxas shows ...

According to latest report, the global DNA and gene chip market size is calculated at USD 11.44 billion in 2024 and is projected to hit around USD 30.72 billion by 2033, expanding at a CAGR of 11.6% ...

As per precedence Research, the global DNA microarray market size is projected to grow approximately USD 6.13 billion by 2034 from valued at USD 2.28 billion in 2023. It is expanding at a CAGR of 9.4% ...

Chart House, a waterfront seafood-and-steak joint in Philadelphia, is closing next month after 38 years, the restaurant's parent company Landry's said. The restaurant sits on a pier on the Delaware ...